Comparison Efficacy in Patients With Asthma Using Foster MDI and Relvar Medications
- Registration Number
- NCT04185129
- Lead Sponsor
- Far Eastern Memorial Hospital
- Brief Summary
This is a randomized study to compare asthma patients using Foster or Relvar.
- Detailed Description
The Global Asthma Association (GAA) and the World Allergy Organization (WAO) recently issued statements stating that the small airway is caused by asthma and chronic obstructive pulmonary disease (COPD). Both pathogenesis and treatment play an important role. The small airway is an airway with diameter less than 2 mm and is one of the main sites where airflow obstruction occurs. Small particles (\<2 μm) and large particles are more likely to deposit in the distal airways, and have shown to have better effects on asthma and pulmonary obstruction. At the same time, real-life research has also shown that extra-fine particles provide better asthma control than large particles, and can better improve quality of life.The aim of the study is to compare the efficacy of asthma inhalers between extra-fine particles and non-extra-fine particles.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 200
- patients diagnosis with asthma with treatment naive
- asthma patients with poor controlled status
- COPD
- smoking history
- pregnancy
- cardiaovascular disease
- patients with acute respiratory infection
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Foster Foster uncontrolled asthma patients were randomized into Foster treatment group Relvar Foster uncontrolled asthma patients were randomized into Relvar treatment group
- Primary Outcome Measures
Name Time Method Lung function improvement one year FEV1
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Far Eastern Memorial Hospital
🇨🇳Taipei, Taiwan